Research on the impact of ACE-i and ARBs for patients with COVID-19 continues to evolve

Thursday, September 10, 2020 - 19:00 in Health & Medicine

Low blood pressure, or hypotension, in COVID-19 patients with a history of hypertension appears to be a risk factor for kidney damage and death. Reducing hypertension medications if and when COVID-19 patients become hypotensive could prevent acute kidney injury and death, according to a new study. A different study confirmed hypertension is the most common co-existing disease in hospitalized COVID-19 patients. A third, small study found hospitalized, COVID-19 patients previously taking the blood pressure-lowering drugs angiotensin-converting enzyme inhibitors (ACE-i) and angiotensin receptor blockers (ARBs) are more likely to die than those who were not taking the medications.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net